Symptoms such as forgetfulness, loss of concentration and disorientation can be early signs of dementia or Alzheimer’s disease (AD). Click this link to view the entire study: Ask The Experts bookmark Let’s Ask……. The Experts Aiding People With … Continued
A new study by Georgetown University done on nicotinamide adenine diclonucleotide (NADH), a coenzyme found in all living cells, revealed that a “significant number of patients with CFS showed marked improvement.” The double-blind clinical trial began in April 1996 and … Continued
Click this link to view the entire study: Down Syndrome and Alzheimers The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer’s disease. Kim SH, Vlkolinsky R, Cairns N, … Continued
NEW FOLLOW-UP STUDY SHOWS THAT A NATURALLY OCCURRING COENZYME NUTRITIONAL SUPPLEMENT ENADA® NADH CLINICALLY DEMONSTRATES BENEFITS FOR ALZHEIMER’S PATIENTS To read the study please click this link : Nov 2002 ICMAN Study on Alzheimers 2nd International Conference on Mechanisms and … Continued
Objective: To evaluate the effect of stabilized oral NADH (reduced nicotinamide adenine dinucleotide; ENADA®) on cognitive functioning in patients with AD. To read the study please click this link : 2002 Treatment of Alzheimers Double Blind Study Treatment of … Continued
Summary: This study was designed to evaluate the effect of stabilized oral reduced nicotinam,de adenine din ucleotide (NADH) on cognitive functioning in patients with Alzheimer’s dsease (AD). NADHis a coenzyme that plays a key role in cellular energy production and … Continued
Although significant progress has been achieved in revealing the etiology of AD, the search for efficient therapy stays the man goal. Nicotinamide adenine dinucleotide (NADH) is biologically identified as a cofactor necessary for a number of cellular actions, such as … Continued